# Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)

> **NCT01163942** · PHASE3 · TERMINATED · sponsor: **European Society for Blood and Marrow Transplantation** · enrollment: 205 (actual)

## Conditions studied

- Aplastic Anaemia

## Interventions

- **DRUG:** G-CSF
- **DRUG:** Early retreatment with ATG

## Key facts

- **NCT ID:** NCT01163942
- **Lead sponsor:** European Society for Blood and Marrow Transplantation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-03
- **Primary completion:** 2008-06
- **Final completion:** 2010-11
- **Target enrollment:** 205 (ACTUAL)
- **Why stopped:** Ceased production of the study drug, Lymphoglobulin. Recruitment of patients onto the trial was too slow.
- **Last updated:** 2026-04-24

## Collaborators

- Sanofi

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163942, "Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01163942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*